We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Azure Hlgs | LSE:AZH | London | Ordinary Share | GB00B1CRL578 | ORD 0.2P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | 0 | GBX |
Azure (AZH) Share Charts1 Year Azure Chart |
|
1 Month Azure Chart |
Intraday Azure Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 18/11/2021 | 22:58 | Rsv Shareholder's Action Group | 5,338 |
| 03/2/2008 | 10:58 | Azure Holdings (formerly Room Service) - Re-Listing - Any thoughts ?? | 16 |
| 05/10/2006 | 18:17 | AZH: Azure holdings - a new beginning | 442 |
| 31/7/2004 | 15:38 | AZH - - - Let's see what the next trick is for the circus clowns | 23 |
| 25/3/2004 | 17:15 | Azure holders thread | 143 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 04/10/2006 20:38 by alan82 valirx's market cap was 12m£ on the first day of trading! at what price did the buyers get in at? was the big sell order profit taking? i think this stock is massivly overbought in the short term, so its got to come down slightly, which it has done so it should start rallying up! |
Posted at 04/10/2006 13:14 by uknighted Someone should tell ADVFN that Valirx is not the same as Valspar - see "The latest Valirx News Headlines" on the Valirx share price quotation page!! |
Posted at 04/10/2006 08:41 by martin c-j For those of you that don't know, AZH is now trading as ValiRx. The new ticker symbol is VAL.L. You also have one share of VAL for every two shares of AZH that you used to have. ie if you had 10,000 shares of AZH, you should now have 5,000 shares of VAL.L. Good luck. |
Posted at 03/10/2006 14:55 by uknighted The rise is because of the share consolidation. The shares are now Ordinary 0.2p replacing the Ordinary 0.1p. |
Posted at 28/9/2006 12:10 by dell314 alia - What justification do you have for your target?That figure would give AZH a mkt cap of £26mln(£32mln if the additional vendor shares are issued!). Doesn't that sound a bit ridiculous? I'll be very surprised if the share price doesn't nosedive once the offloading of stock by penny share pushers onto PIs ends..... All IMHO, DYOR etc. Rgds dell |
Posted at 17/9/2006 10:11 by dusseldorf jmillskeel - I took the 11.2p (equivalent) offer from Evo a while ago so got my money back, I gave the small profit I made to the RSV shareholders fund. Subsequently I've been accumulating AZH as I have always believed a reverse aquisition was going to go ahead. My average before suspension was 0.32p/share following some late purchases prior to suspension. Sold out most now though still holding 100k.If you're still holding I believe 2p+ is possible given any further fundraising will be off the back of positive drug updates and given 90% roughly will be closely held the price will surge. I'm not patient enough for that so have 1.25 - 1.5p target for the remainder. Keep your eye on DMR over the next few months, ignore smilers enthusiastic ramping there is actually huge potential there. |
Posted at 04/8/2006 14:53 by dell314 Van - That's the problem with a nominee account. They may be cheaper but you don't get company reports and all the other documentation.However, realistically, unless the official documentation contained much more information than the RNS, I can't see why people would stump up money for the convertible. There certainly wasn't enough in the RNS to convince me whether or not it was a credible proposition. Incidentally, didn't AZH try a fundraising shortly after the RSV debacle and only end up raising about twenty pence?? FWIW, has anyone reading these threads had full documentation and in a position to shed a little more light on the financial details of the convertible and proposed acquisition? All IMHO, DYOR etc. Rgds dell P.S. VQ - You had a right to purchase the convertible, if you so wished. How your shares are held makes no difference to the fact that you are shareholder. |
Posted at 04/8/2006 13:45 by very quick So it is possible that AZH may return at 12p as that makes a Market Cap of 11.4 million???? with the same amount of shares in issue????Last share price close was 0.300p with Market Cap of £190,000 How many shares will the new company have???? and at what price???? |
Posted at 30/5/2005 11:03 by anomalous Here are the previous articles on White Nile. Now if you read the email I sent to the LSE Complaints Commissioner, you will see that the LSE suspending White Nile is exactly the action they should have taken with Room Service. Therefore we have conclusively proved that the LSE was negligent in failing to suspend Room Service when they could have and losses suffered by investors afterwards were partially the responsibility of the Exchange for their failure to do their duty.White Nile shares suspended after Stock Exchange raises concerns By Stephen Foley The Independent 28 May 2005 The saga of White Nile, Phil Edmonds' oil exploration venture in Sudan, took another twist yesterday when the London Stock Exchange again halted trading in the company's shares, just four days after the stock returned from suspension. The regulator said it feared there could not be an orderly market in the shares, which surged 1,275 per cent in the days after floating on AIM in February, and has again proved volatile this week. The founding shareholders  including the former England spin bowler Edmonds, its chairman, who owns 9.7 per cent  have been unwilling to sell, leaving speculators chasing a small number of freely traded shares. This week, the Exchange warned against short selling White Nile shares. Short sellers sell stock they do not own in the expectation that they will be able to buy it back cheaper at a later date, but the Exchange said it did not believe there were enough White Nile shares available to be able to settle the trades. The company said yesterday it would issue new shares to ease the problem and to raise new funds for investment in Sudan. But the vague nature of White Nile's statement proved the last straw for the Stock Exchange, which suspended trading 20 minutes later, citing "concerns over the orderliness of the market". White Nile was established as a cash shell, but it is buying oil exploration rights from the state oil company of the newly autonomous south Sudan. The shares had been suspended for three months because the Stock Exchange demanded a detailed prospectus for the deal. That was finally published last week. The shortage of stock has been the main reason for the strength of White Nile shares since they returned from suspension on Monday, confounding predictions that they could halve in value. Instead, they had risen by 27 per cent by yesterday morning's peak, valuing the company at £270m, before sliding sharply after the announcement of the fund raising. White Nile's statement gave no details on the size of a proposed placing, or at what level it may be priced. It said it has almost completed arrangements and would announce details early next week. A spokeswoman said: "Although the company said that it would need to raise some money at some point, it has been decided to tie everything up at once. It needed to increase liquidity, it has been told to increase liquidity, so it will issue new shares." Arch-bear shows no fear as Nile surges Mickey Clarke and Steve Hawkes, Evening Standard 27 May 2005 YOU could smell the testosterone today as share dealings in controversial oil explorer White Nile sent its price soaring 38%, or 48p, to a record 174p - way above the 138½p at which the shares returned from suspension on Monday and valuing the company at £261m. In the blue corner is former England cricketer Phil Edmonds, who founded the company, and his influential institutional shareholders RAB Capital, Artemis and US Global. In the red corner is arch-bear Simon Cawkwell, aka Evil Knievil, the man who strikes fear into companies by selling their shares short. He recently shorted 250,000 shares at prices ranging from 10p to 15p and, despite other bears now scrambling to close their bets and avert any more losses, he is showing few signs of buckling. Today it emerged he has shorted a further 100,000 shares at 115p. He said: 'I am not worried in the slightest about White Nile. I am under no pressure to close my position.' Cawkwell is scathing of those who have quit the stock after broker Evolution Securities earlier this week demanded delivery of 165,000 shares lent out to the bears. 'Some men should stay at home and do the ironing. I have got balls of iron,' he said. White Nile has struck a deal to explore for oil in South Sudan and was floated back in February at just 10p. Edmonds' business partner Andrew Groves said today: 'The shorts have to take their punishment when it comes.' White Nile paves the way to unlock holdings By Yvette Essen Daily Telegraph (Filed: 28/05/2005) White Nile, the oil exploration group partly owned by former England spin bowler Phil Edmonds, last night agreed to allow shareholders who are effectively locked into their investment to sell up to 35pc of their holding. The move came after shares were suspended for a second time yesterday after the stock surged 38pc in a bear squeeze. White Nile shares soared 48 to 174p at one point, as the bears of the stock rushed to cover their positions in a highly illiquid market. The scramble followed a warning from the London Stock Exchange about settlement difficulties in share trades. The bears' search for stock had been made more challenging by undertakings from 99pc of White Nile's existing shareholders to vote in favour of its controversial acquisition of a 60pc stake in a South Sudanese oil concession at an extraordinary meeting on June 16. The directors, who together hold almost 20pc of the shares, will continue to be locked into their investment until next February. The Exchange temporarily halted trading in the shares because of concerns about the "orderliness of the market". It followed an announcement by White Nile that it had almost completed arrangements for a share placing to improve liquidity and raise fresh capital. Dealings will resume next week. Since listing on the Alternative Investment Market at 10p in February, the shares have rocketed. They climbed to 138½p in the first five days of dealings, before trading was suspended, ahead of details of the planned South Sudan deal. When dealings were resumed on Monday the shares, which had been expected to plummet after rival claims to rights in South Sudan, dipped just 12 to 126p, supported by bear covering. Oil explorer stuck as shares suspended for second time The Scotsman 28 May 2005 THE rollercoaster debut on the stock market of oil explorer White Nile continued yesterday when its shares were suspended on AIM for a second time. It came four days after trading in White Nile recommenced for the first time since February when its shares shot up 13-fold in less than a week. White Nile halted by LSE after shares soar by up to 38% By Peter Klinger The Times May 28, 2005 THE London Stock Exchange suspended trading in White Nile after shares in Phil Edmonds's speculative oil vehicle soared by up to 38 per cent. The intervention adds to the farce surrounding White Nile, which listed on AIM in February but due to lengthy suspensions has traded for only two weeks. Those two weeks, however, have been sufficient for White Nile's tightly held shares to soar from their 10p float price to as high as 176p yesterday. The shares were trading at 141p, up 15p, when AIM's regulators suspended trading. The suspension was triggered by the regulators's concerns at a lack of "orderliness" in White Nile share trading. Its shareholder base is close-knit and those investors who had shorted the stock, on expectations that a much-hyped oil deal in southern Sudan would collapse, have this week scrambled to cover their positions. Complicating matters is that 99 per cent of White Nile's shareholders have irrevocably backed the oil deal, under which southern Sudan's rebel government will take a 50 per cent stake in the company. The support effectively leaves only an estimated one million White Nile shares as free float, compared with about 3.5 million shares worth of short positions. Neither White Nile nor Numerica, its financial adviser, would comment on the suspension. Mr Edmonds is understood to be abroad. However, a market maker in White Nile criticised AIM's intervention. An AIM spokesman said: "The exchange suspended the shares of White Nile because of concern over the orderliness of the market." White Nile became the latest in a stable of stocks promoted by Mr Edmonds, the former England cricketer. Like several of his other ventures, White Nile's shares were tightly held when the company floated. However, excitement about the potential of a deal in Sudan propelled White Nile's share price, fuelled further by the free-stock shortage. Mr Edmonds was forced to call for a suspension of trading only a week after White Nile listed while he finalised the Sudanese deal. The shares returned to trading on Monday, after a three-month suspension, and defied pessimists by retaining much of their pre-suspension value. Under the Sudan deal White Nile will receive a 60 per cent stake in the Block Ba oilfield, which experts could contain up to five billion barrels of oil. |
Posted at 29/8/2004 17:27 by anomalous Here's the article by WDurham on Stockgate:Stockgate" and Naked Shorting – Is it Happening Here? by Wendy Durham 1st June 2004 -------------------- Tuesday 1st June 2004 Naked shorting is the sale of fictitious shares – i.e. the seller either is NOT required to make an undertaking that he can or will deliver the stock he has sold, or simply fails to deliver. This practice – thought by many to be immoral - is quite capable of bringing a blameless small company to its knees through no fault of its own, although it is fair to say that some weak organisations do cite it as an excuse for their own poor share price performance. On 1st April 2004, new regulations in the US made the practice of naked shorting just about impossible, by requiring that sellers of any stock must be able to deliver the sold shares within 2 days of settlement. Between January and April, hundreds of US companies found themselves listed in Berlin, on the Berlin Stock Exchange, without their knowledge or consent. Why might this be? An overview of what is being called "Stockgate" appears here: The Financial Times had this to say: Another of the many commentaries from the US is here: All of these cite the "arbitrage exception" to the naked shorting rules as being a loophole which can be used now that these companies are listed on a foreign exchange. The wording of this exception – Rule 10a-1 (e)(8) is as follows: (NB – "paragraphs (a) and (b) of this section" refers to the short selling rules) (e) The provisions of paragraphs (a) and (b) of this section (and of any exchange rule adopted in accordance with paragraph (a) of this section) shall not apply to: (8) Any sale of a security registered on, or admitted to unlisted trading privileges on, a national securities exchange effected for a special international arbitrage account for the bona fide purpose of profiting from a current difference between the price of such security on a securities market not within or subject to the jurisdiction of the United States and on a securities market subject to the jurisdiction of the United States; provided the seller at the time of such sale knows or, by virtue of information currently received, has reasonable grounds to believe that an offer enabling him to cover such sale is then available to him in such foreign securities market and intends to accept such offer immediately; Nowhere is the actual use of this loophole spelled out – but the implication appears to be that the stock is SOLD in the domestic market, in anticipation of immediately BUYING at a lower price in the overseas market to cover the sale and make a profit from the difference in price. However, for this to be a "loophole", there must be an advantage to the US seller – thus one can speculate that if the seller then fails to purchase in the foreign market, the wording of "reasonable grounds to believe" appears to permit any number of excuses for such failure to cover the short. In the meantime, the now-naked short remains open....or is eventually settled via the stock borrow program of the US Depositary Trust and Clearing Corporation (DTC). So what has this to do with UK listed companies? Go first to Choose About Us Choose New Companies Choose Listings Then browse through the pages to understand the sheer scope and scale of what was done in just a few weeks during March and April 2004. Allegedly, the bulk listings began earlier than this, but I cannot find evidence of dates on the BSE's website prior to 1st March. 145 UK listed companies – largely small caps and speculative stocks – have been listed on the Berlin Exchange since 1st March. At the same time, hundreds more companies from all over the world, but mainly from the US and Canada, were also listed, largely by the same brokers - 1170 and 1172. It is notable that the majority of companies listed are small cap and/or speculative stocks, particularly the huge number of mining and exploration vehicles. A Google search turns up very many US companies complaining bitterly that within only weeks of the effective outlawing of naked shorting in the US on 1st April, they have discovered that they are now exposed WITHOUT THEIR KNOWLEDGE OR CONSENT to the same activity via – apparently - the arbitrage loophole. The Berlin Stock Exchange deny that the exchange is being used for naked shorting, but it is a remarkable coincidence that highly speculative US short targets, many of them already in severe trouble, suddenly end up - in their hundreds - listed on a foreign exchange within a very "short" period indeed of the ending of the practice in the US. It is a fact that one of the complainants, Goldspring, which now appears to have been removed from trading, had been listed in Berlin in late November 2003. Its price experienced a fairly volatile rollercoaster ride, from 0.45 Euros in November to approximately 0.8 Euros by mid-Feb. On 1st April the price in Berlin was 0.7 Euros, but immediately began to fall sharply, and by early May, when Goldspring requested the removal of their listing, the price was down to 0.4 Euros. Interestingly, no volume AT ALL was recorded for the stock during the entire period of its listing – a common feature of the recently listed US and UK stocks. There is virtually NO trading going on in Berlin in the shares of these companies. Which once again raises the question: why were they listed? Are UK companies also being targeted via a similar route? Of small cap UK companies that have suffered recently, Bioprogress and Proteome Sciences spring to mind. Both have halved from recent highs, partly due, it has been thought, to organised shorting by hedge funds intent on destabilising a substantial margin trade position to bring the stocks ever lower Proteome Sciences (PRM.BE) has been listed on the Berlin Stock Exchange since Autumn 2000. Bioprogress – as discovered by a sharpeyed ADFVN bulletin board poster known as "Scram" - was listed on 21 April 2004 (BPRG.BE). Both companies are known in the US through an earlier listing on the OTCBB in the case of BPRG, and commercial relationships in the case of PRM. On 1st April – the day from which the focus of US naked shorters was switched to stocks listed in Berlin - Proteome was standing at £1.90 per share, having reached £2.30 on an earlier high, and had been trading steadily for the previous month in the £2.10 - £1.90 range. Bioprogress had come off an earlier unsustainable high at £1.60 to a 6-week trading range of £1.00 - £1.20. On 1st April, Proteome Sciences' share price began to fall sharply and by 28th April had reached 90p. On 29th April, just 8 days after listing in Berlin, Bioprogress began a rapid descent to 75p by 14th May . Neither have recovered more than a fraction of their earlier highs. Coincidence? Perhaps – but perhaps not. Many companies have had a hard time of it during April and May, which has been put down to poor market conditions, macroeconomic effects throughout the world, and general underperformance. In the particular cases of Bioprogress and Proteome, traders were becoming increasingly nervous as expected commercial deals failed to materialise. However, six other UK companies were listed in Berlin on the same day as Bioprogress – 21st April. Their short term charts make interesting reading: Regal Petroleum – share price declined from 10 May Pipex Comms – share price began a decline at the end of March, which has steepened since 29 April. RAB Capital – share price commenced a decline on 20 April, corrected a little on 26 April, but resumed an overall downtrend on 28th African Gold – share price decline commenced 22 April, flattened off from 26 April – 6 May, and then resumed the downtrend. Oystertec – follows a similar pattern to Pipex, though the price has since recovered ASK Central – the company was under offer, which became conditional in early May – hence there was no share price effect. Several more UK companies were listed on 28 April. Of these: Supercart's price – already in decline from 54p to 36p – fell to 23p between 29 April and 20 May. Visonic, after two weeks of trading sideways, commenced falling sharply on 30 April Omega Int began to fall from £1.23 on 4 May to £1.04 by 20 May The charts of two more companies listed on that day, Dignity and Polaron, show them to have been good short candidates. Dignity had experienced a sharp rise – and Polaron appeared to be rapidly declining. However, neither appeared to have suffered ill-effects after their Berlin listing. Another group of UK companies were listed in Berlin on 1 March 2004. A review of their charts is even more interesting! The companies involved are Golden Prospect, Gold Mines of Sardinia, Glencar Mining, Eurasia Mining, Avocet Mining, Randgold, African Eagle, Oxus Gold, Griffin Mining and Tertiary Minerals. It is worth noting that most of the UK companies listed since 1 March are highly speculative, many illiquid, and several were already excellent short candidates. In fact, one has to wonder why this relative handful of 145 companies have been added at all, if it were not for the fact that most of them, at some point, will be or have been first rate shorts. All the above looks at only a few of the UK companies listed in Berlin during the last 3 months, and any evidence that they are being targeted by naked shorters is purely circumstantial. However, the charts and the general absence of any trading in these stocks on the Berlin Exchange do appear to be telling a story. It is clear that there are many more UK companies enjoying a Berlin listing, in addition to the 145 that have been listed since 1st March this year. A random input of various UK tickers, particularly those of speculative stocks, into the Berlin Exchange's search facility turns up a result in many cases. Some will no doubt have chosen to be listed there – others may as yet be unaware. How many more of these older listings are now increasingly vulnerable to a shorting community focused on the Berlin exchange? Proteome Sciences might be a salutary example. Finally - could it be that the "generally poor market conditions" which have been given as a reason for sliding prices in many UK listed smallcap and speculative stocks have been a symptom rather than a cause? Wendy Durham 1st June 2004 This article is the copyright of Fillyaboots.com and may NOT be reproduced or copied elsewhere without our written permission. You are however, welcome to quote extracts provided it is properly attributed and refer to it wherever you wish using the following link |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
